tiprankstipranks
Omega Therapeutics reports Q3 revenue $2.61M, consensus $1.34M
PremiumThe FlyOmega Therapeutics reports Q3 revenue $2.61M, consensus $1.34M
8d ago
Omega Therapeutics Restructures Leadership and Strategic Focus
Premium
Company Announcements
Omega Therapeutics Restructures Leadership and Strategic Focus
8d ago
Omega Therapeutics Welcomes Robert Rosiello to Board
Premium
Company Announcements
Omega Therapeutics Welcomes Robert Rosiello to Board
2M ago
Omega Therapeutics announces election of Richard Kender to its  board
PremiumThe FlyOmega Therapeutics announces election of Richard Kender to its board
5M ago
Omega Therapeutics initiated with an Outperform at Raymond James
Premium
The Fly
Omega Therapeutics initiated with an Outperform at Raymond James
5M ago
Omega Therapeutics Appoints New Chief Business Officer
Premium
Company Announcements
Omega Therapeutics Appoints New Chief Business Officer
6M ago
Omega Therapeutics CFO Joshua Reed to depart
PremiumThe FlyOmega Therapeutics CFO Joshua Reed to depart
7M ago
Omega Therapeutics presents preclinical data on precision epigenomic control
Premium
The Fly
Omega Therapeutics presents preclinical data on precision epigenomic control
8M ago
Omega Therapeutics price target lowered to $9 from $10 at Piper Sandler
Premium
The Fly
Omega Therapeutics price target lowered to $9 from $10 at Piper Sandler
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100